Related Experiment Videos
[Treatment with a piperacillin and netilmicin combination of patients with agranulocytosis]
R Herbrecht1, J P Bergerat, J C Langs
1Service d'Onco-Hématologie, Hôpital de Hautepierre, Strasbourg.
Pathologie-Biologie
|May 1, 1988
Abstract:
Sixty infections episodes in granulocytopenic patients have been treated in first line with a piperacillin and netilmicin combination. Treatment has been successful in 78% bacterial infections. So, this antibiotic combination appears as a very effective therapy of infection in neutropenic patients.
Insights
This study shows that combining piperacillin and netilmicin effectively treats bacterial infections in granulocytopenic patients. This antibiotic combination offers a successful first-line therapy option for neutropenic infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Hematology
Background:
- Granulocytopenic patients are highly susceptible to infections.
- Prompt and effective antibiotic therapy is crucial for managing infections in this vulnerable population.
Purpose of the Study:
- To evaluate the efficacy of a piperacillin and netilmicin combination as a first-line treatment for infections in granulocytopenic patients.
- To determine the success rate of this antibiotic combination in treating bacterial infections.
Main Methods:
- A prospective study involving sixty infection episodes in granulocytopenic patients.
- Treatment administered as a first-line therapy using piperacillin and netilmicin combination.
Main Results:
- The piperacillin and netilmicin combination demonstrated a high success rate.
- Successful treatment was observed in 78% of bacterial infections evaluated.
Conclusions:
- The combination of piperacillin and netilmicin is a highly effective first-line therapy for infections in neutropenic patients.
- This antibiotic regimen shows significant promise in managing serious infections in immunocompromised individuals.